Jay Thakkar of Sharekhan advises buying Bliss GVS Pharma with a target of Rs 187.
Mitessh Thakkar of miteshthacker.com recommends buying Eveready Industries, NBCC, Colgate Palmolive and Godrej Consumer Products.
Ashish Kyal of Waves Strategy Advisors advises buying Natco Pharma with a target of Rs 965.
Mitessh Thakkar of miteshthacker.com recommends buying Eveready Industries and Ajanta Pharma.
Ruchit Jain of Angel Broking advises buying Pidilite Industries with a target of Rs 742.
Motilal Oswal is bullish on Eveready Industries has recommended buy rating on the stock with a target price of Rs 335 in its research report dated May 06, 2016.
Eveready Industries MD, Amritanshu Khaitan pointed out that FY16 volumes for Eveready will remain flat due to Chinese dumping. He expects the industry to see double digit growth in the coming year if the planned anti-dumping duty is strictly imposed.
For the current October-December quarter, Amritanshu Khaitan, ED of Eveready Industries expects volumes to remain flat because of the price increase. On the positive side, he feels input cost will come down now that rupee has stabilised at around 62-63/ USD from 64-65/ USD levels.
Eveready Industries' Amritanshu Khaitan is upbeat on the company's growth and hopes to maintain margins of 8 percent in H2FY14. Also, good monsoons and compulsory digitisation will further improve the growth of the company, he adds.
Prakash Diwan of Altamount Capital recommends going long on Glenmark Pharma with a target of Rs 586 and NCC with a target of Rs 22.50.
Vishal Malkan of malkansview.com advises selling Rural Electrification Corporation October future with a target price of Rs 184 and Indiabulls Real Estate October future with a target price of Rs 60.
According to Amritanshu Khaitan, Eveready Industries is likely to maintain margins at around 8 percent for the full year. The company recently increased its battery prices to battle cost pressures due to rupee depreciation.
Speaking on the back of Q4 results for FY13, Amritanshu Khaitan told CNBC-TV18 that he expected a turnover growth of 10-15 percent for FY14. With better operations, he expects a better bottomline for FY14.
Jagannadham Thununguntla, Strategist & Head of Research, SMC Global Securities advises to remain invested in Eveready Industries.
In CNBC-TV18's popular show Bull's Eye, Pankaj Jain of Sunteck Wealthmax shares trading strategy of the day.
Eveready posted a near 31 percent decline in net profit to Rs 2.08 crore for the quarter ended September 30 compared with Rs 3.03 crore in the year-ago period. Its net sales grew 12 percent to Rs 286.64 crore. During the same period last year, net sales stood at Rs 255.93 crore.
Devang Mehta, Anand Rathi Financial Services is of the view that exit Eveready Industries India and buy Havells India.
HDIL sold Eveready Industries plot at Turbhe for an Rs 42 crore loss, reports CNBC-TV18.
Eveready Industries had indicated to sell its 25 acre Hyderabad based land. Last quarter wasn’t great for Eveready; primarily it was on account of high raw material cost, foreign exchange devaluation.
Speaking to CNBC-TV, Deepak Khaitan, vice chairman of Eveready Industries, said that its battery business is going to be a growth driver for FY12.
Battery maker Eveready Industries India reported a fourth quarter (January-March) net profit of Rs 3.87 crore, down over 96% year-on-year due to lower sales and a one-time exceptional gain in the year ago quarter.
Eveready Industries Q3 net profit at Rs 6.6 crore versus Rs 11 crore.
In an interview with CNBC-TV18, Deepak Khaitan, Executive Vice Chairman, Eveready Industries, spoke about the results and his outlook for the company.